|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net income | |||
| Adjustments to reconcile net income to cash provided by (used for) operating activities: | |||
| Impairment charges | |||
| Foreign exchange (gain) loss on debt | |||
| Depreciation, depletion and amortization | |||
| Share-based compensation expense | |||
| Deferred income tax benefit | |||
| Gain on sale of investments and property, plant and equipment | |||
| Results from affiliates | |||
| Other, net | |||
| Changes in operating assets and liabilities, excluding the effects of acquisitions and dispositions: | |||
| Trade accounts receivable | |||
| Inventories | |||
| Secured advances to suppliers | |||
| Trade accounts payable and accrued liabilities | |||
| Advances on sales | |||
| Net unrealized (gains) losses on derivative contracts | |||
| Margin deposits | |||
| Recoverable and income taxes, net | |||
| Marketable securities | |||
| Beneficial interest in securitized trade receivables | |||
| Other, net | |||
| Cash provided by operating activities | |||
| INVESTING ACTIVITIES | |||
| Payments made for capital expenditures | |||
| Acquisitions of businesses (net of cash acquired) | |||
| Proceeds from investments | |||
| Payments for investments | |||
| Settlements of net investment hedges | |||
| Proceeds from beneficial interest in securitized trade receivables | |||
| Payments for beneficial interest in securitized trade receivables | |||
| Proceeds from disposal of business and property, plant and equipment | |||
| Proceeds from sale of investments in affiliates | |||
| Payments for investments in affiliates | |||
| Other, net | |||
| Cash used for investing activities | |||
| FINANCING ACTIVITIES | |||
| Net change in short-term debt with maturities of three months or less | |||
| Proceeds from short-term debt with maturities greater than three months | |||
| Repayments of short-term debt with maturities greater than three months | |||
| Proceeds from long-term debt | |||
| Repayments of long-term debt | |||
| Debt issuance costs | |||
| Proceeds from the exercise of options for common shares | |||
| Repurchases of registered or common shares | |||
| Dividends paid to preference shareholders | |||
| Dividends paid to registered, common or preference shareholders | |||
| Dividends paid to noncontrolling interests | |||
| Capital contributions (return of capital) from noncontrolling interests, net | |||
| Sale of noncontrolling interest | |||
| Acquisition of redeemable noncontrolling interest and noncontrolling interest | |||
| Settlement of cross currency swap | |||
| Other, net | |||
| Cash provided by (used for) used for financing activities | |||
| Effect of exchange rate changes on cash and cash equivalents, and restricted cash | |||
| Net (decrease) increase in cash and cash equivalents, and restricted cash | |||
| Cash and cash equivalents, and restricted cash - beginning of period | |||
| Cash and cash equivalents, and restricted cash - end of period |
Loading...
